<DOC>
	<DOC>NCT00758953</DOC>
	<brief_summary>This study will evaluate the efficacy and safety of an investigational medication compared with placebo in the treatment of pain associated with endometriosis.</brief_summary>
	<brief_title>Pain Associated With Endometriosis</brief_title>
	<detailed_description />
	<mesh_term>Endometriosis</mesh_term>
	<mesh_term>Danazol</mesh_term>
	<criteria>Menstruating female 1850 years of age, Regular cycle length of 21 to 35 days with menstrual bleeding that typically lasts no more than 7 days, Has pain associated with endometriosis, Has a documented history consistent with endometriosis, Is pregnant or lactating, Has a history of or has active thrombosis</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>